|Min SIP Amount||₹100|
|NAV||₹142.88 (13 Sep 2019)|
|Fund Started||05 Jun 2004|
|Fund Size||₹2,377 Cr|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||12.3%|
|Divi's Laboratories Ltd.||Healthcare||Equity||10.3%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||8.3%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||7.0%|
|Abbott India Ltd.||Healthcare||Equity||6.8%|
|Syngene International Ltd.||Healthcare||Equity||6.5%|
|Fortis Healthcare (India) Ltd||Healthcare||Equity||6.0%|
|Sanofi India Ltd.||Healthcare||Equity||5.8%|
Reliance Pharma Fund Growth is a Equity Mutual Fund Scheme launched by Reliance Mutual Fund. This scheme was introduced to investors on 05 Jun 2004. Sailesh Raj Bhan is the Current Fund Manager of Reliance Pharma Fund Growth.The fund currently has an Asset Under Management(AUM) of ₹2,377 Cr and the Latest NAV as of 13 Sep 2019 is ₹142.88.
The Reliance Pharma Fund Growth is rated High risk. Minimum SIP Investment is 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 year.
1st Floor, Proms Complex, SBI
Colony, 1A Koramangala, 560034